Choudhary, Rishabh C.
Ahmed, Umair
Shoaib, Muhammad
Alper, Eric
Rehman, Abdul
Kim, Junhwan
Shinozaki, Koichiro
Volpe, Bruce T.
Chavan, Sangeeta
Zanos, Stavros
Tracey, Kevin J.
Becker, Lance B. http://orcid.org/0000-0001-7051-8778
Funding for this research was provided by:
United Therapeutics Corporation
ZOLL Foundation
Article History
Received: 30 May 2022
Accepted: 24 June 2022
First Online: 20 July 2022
Declarations
:
: The authors confrm that the study was approved by the Committee on the Ethics of Animal Experiments of the Feinstein Institutes for Medical Research (Protocol Number: 2016–009).
: Not applicable.
: KJT and SC has multiple patents on VNS. LBB has a grant/research support from Philips Healthcare, the NIH, Nihon Kohden Corp., Zoll Medical Corp, PCORI, BrainCool, and United Therapeutics; LBB owns several issued and pending patents involving the use of medical slurries as human coolant, devices to create slurries, reperfusion cocktails, and measurement of respiratory quotient. All other authors declare no competiting interest.